Crothers Kristina, Butt Adeel A, Gibert Cynthia L, Rodriguez-Barradas Maria C, Crystal Stephen, Justice Amy C
Pulmonary and Critical Care Medicine, Department of Internal Medicine, Yale University School of Medicine, New Heaven, CT, USA.
Chest. 2006 Nov;130(5):1326-33. doi: 10.1378/chest.130.5.1326.
Limited data prior to highly active antiretroviral therapy (HAART) suggested the possibility of an increased risk of COPD among those persons with HIV infection. We sought to determine whether HIV infection is associated with increased prevalence of COPD in the era of HAART.
Prospective observational study of 1,014 HIV-positive and 713 HIV-negative men who were enrolled in the Veterans Aging Cohort 5 Site Study. COPD was determined by patient self-report and International Classification of Diseases, ninth revision (ICD-9), diagnostic codes. Cigarette smoking and injection drug use (IDU) were determined by self-report, and alcohol abuse was determined by ICD-9 diagnostic codes. Laboratory and pharmacy data were obtained from electronic medical records.
The prevalence of COPD as determined by ICD-9 codes was 10% in HIV-positive subjects and 9% in HIV-negative subjects (p = 0.4), and as determined by patient self-report was 15% and 12%, respectively (p = 0.04). After adjusting for age, race/ethnicity, pack-years of smoking, IDU, and alcohol abuse, HIV infection was an independent risk factor for COPD. HIV-infected subjects were approximately 50 to 60% more likely to have COPD than HIV-negative subjects (by ICD-9 codes: odds ratio [OR], 1.47; 95% confidence interval [CI], 1.01 to 2.13; p = 0.04 ; by patient self-report: OR, 1.58; 95% CI, 1.14 to 2.18; p = 0.005).
HIV infection was an independent risk factor for COPD, when determined either by ICD-9 codes or patient self-report. Health-care providers should be aware of the increased likelihood of COPD among their HIV-positive patients. The possibility that HIV infection increases susceptibility to and/or accelerates COPD deserves further investigation and has implications regarding the pathogenesis of COPD.
在高效抗逆转录病毒治疗(HAART)之前,有限的数据表明,HIV感染者患慢性阻塞性肺疾病(COPD)的风险可能增加。我们试图确定在HAART时代,HIV感染是否与COPD患病率增加有关。
对参与退伍军人老龄化队列5个站点研究的1014名HIV阳性男性和713名HIV阴性男性进行前瞻性观察研究。COPD通过患者自我报告和国际疾病分类第九版(ICD-9)诊断代码确定。吸烟和注射吸毒(IDU)通过自我报告确定,酒精滥用通过ICD-9诊断代码确定。实验室和药房数据从电子病历中获取。
根据ICD-9代码确定,HIV阳性受试者中COPD的患病率为10%,HIV阴性受试者中为9%(p = 0.4);根据患者自我报告确定,患病率分别为15%和12%(p = 0.04)。在调整年龄、种族/族裔、吸烟包年数、IDU和酒精滥用因素后,HIV感染是COPD的独立危险因素。HIV感染受试者患COPD的可能性比HIV阴性受试者高约50%至60%(根据ICD-9代码:比值比[OR],1.47;95%置信区间[CI],1.01至2.13;p = 0.04;根据患者自我报告:OR,1.58;95%CI,1.14至2.18;p = 0.005)。
无论是通过ICD-9代码还是患者自我报告确定,HIV感染都是COPD的独立危险因素。医疗保健提供者应意识到其HIV阳性患者中患COPD的可能性增加。HIV感染增加对COPD的易感性和/或加速COPD进展的可能性值得进一步研究,并且对COPD的发病机制具有重要意义。